When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Soligenix (SNGX) has a wide pipeline with late-stage candidates in the PDT treatment for various health problems, including Cutaneous T-Cell Lymphoma ((CTCL)), Oral Mucositis, Pediatric Crohn's Disease, and a vaccine candidate for ricin. Unfortunately, the company hasn't managed to bring any product to the market. Recently, Soligenix has gained some attention through an article, which claimed that it can generate more than $500M in revenue if both SGX301 and SGX942 are approved. Note that the company is currently valued at ~ $20M, which is ridiculously cheap compared to the analyst's expectation. We